Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...

Vicarious Surgical (NYSE:RBOT) announced today that it appointed Stephen From as CEO, effective Aug. 7, 2025. Adam Sachs, ...

Last year was the first year that Drug Delivery Business News published a list of the world’s largest diabetes tech companies ...

InspireMD (Nasdaq:NSPR) announced today that it raised approximately $58 million and added an experienced executive to its ...

EvoEndo announced today that it received expanded FDA clearance for its Model LE gastroscope, covering patients of all ages.

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

Maui Imaging announced that it raised $14 million in a Series D financing round to support its echo tomography-based imaging ...

CorTec today announced the first human implantation of its proprietary brain-computer interface (BCI) system, Brain ...

The company — set to be acquired by Zimmer Biomet — said that, on July 26, the first-ever fully autonomous, saw-based robotic ...